Meeting
2017 ASCO Annual Meeting
An intervention study to reduce black-white treatment disparities in early stage non-small cell lung cancer.
Authors
Paul R. Walker
East Carolina University Brody School of Medicine, Greenville, NC
Paul R. Walker , Sam Cykert , Lloyd Edwards , Rohan Arya , Peggye Dilworth-Anderson
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Health Services Research, Clinical Informatics, and Quality of Care
Track
Quality Care/Health Services Research
Sub Track
Access to Care
Clinical Trial Registration Number
NCT01687738
Citation
J Clin Oncol 35, 2017 (suppl; abstr 6560)
DOI
10.1200/JCO.2017.35.15_suppl.6560
Abstract #
6560
Poster Bd #
382
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Stereotactic ablative radiotherapy with nivolumab for early-stage operable non-small cell lung cancer: A phase 2 study.
First Author: Gustavo Schvartsman
Poster
2021 ASCO Annual Meeting
Surgical outcomes for early-stage non-small cell lung cancer at facilities with stereotactic body radiation therapy programs.
First Author: Yusef Syed
Poster
2014 ASCO Quality Care Symposium
Outcomes in stage I non-small cell lung cancer following the introduction of stereotactic body radiotherapy in Alberta, Canada.
First Author: Marc Kerba
Poster
2014 ASCO Annual Meeting
Diffusion of stereotactic body radiotherapy (SBRT) for early-stage non-small cell lung cancer (NSCLC) in the Medicare population, 2007-2009.
First Author: James B. Yu